Eli Lilly’s Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Demand for weight loss and diabetes drugs has trounced supply for months, pushing Eli Lilly and rival Novo Nordisk to invest billions to ramp up manufacturing…
Read More
Reviews
0 %
User Score
Rate This
Sharing
Subscribe
Login
0 Comments
Oldest